First United Bank & Trust’s Iovance Biotherapeutics IOVA Stock Holding History

First United Bank & Trust’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.16K	Hold	1,000	–	–	﹤0.01%	384
2026 Q1	$3.51K	Hold	1,000	–	–	﹤0.01%	364
2025 Q4	$2.73K	Hold	1,000	–	–	﹤0.01%	371
2025 Q3	$2.17K	Hold	1,000	–	–	﹤0.01%	403
2025 Q2	$1.72K	Hold	1,000	–	–	﹤0.01%	379
2025 Q1	$3.33K	Hold	1,000	–	–	﹤0.01%	364
2024 Q4	$7.4K	Hold	1,000	–	–	﹤0.01%	323
2024 Q3	$9.39K	Hold	1,000	–	–	﹤0.01%	315
2024 Q2	$8.02K	Hold	1,000	–	–	﹤0.01%	337
2024 Q1	$14.8K	Buy	+1,000	New	+$11.6K	0.01%	321

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

First United Bank & Trust's IOVA Position: Q2 2026 in Review

First United Bank & Trust held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 1,000 shares worth $4.16K. The position accounts for ﹤0.01% of the portfolio, ranked #384.

First United Bank & Trust first reported a position in IOVA in Q1 2024 and has held it in 10 quarters since. The position peaked at $14.8K in Q1 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

First United Bank & Trust held 1,000 shares of Iovance Biotherapeutics worth $4.16K as of Q2 2026.
First United Bank & Trust left its Iovance Biotherapeutics share count unchanged in Q2 2026.
Iovance Biotherapeutics made up ﹤0.01% of First United Bank & Trust's portfolio in Q2 2026, its #384 holding.
First United Bank & Trust first reported a position in Iovance Biotherapeutics in Q1 2024 and has held it in 10 quarters since.
First United Bank & Trust's Iovance Biotherapeutics position peaked at $14.8K in Q1 2024.
292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on First United Bank & Trust's 13F filing for Q2 2026, filed 20 Jul 2026.